Artificial Organs & Bionic Implants Market: Current Analysis and Forecast (2023-2030)

Artificial organs and bionic implants are revolutionary technologies that aim to restore or enhance the functionality of a specific organ or system in the human body. These advancements have the potential to significantly improve the quality of life for individuals with organ failure, disability, or degenerative diseases. For Instance, as per the data of Organ Procurement & Transplantation Network, in year 2021, 41,354 organ transplants were performed in the United States, an increase of 5.9 percent over 2020. The demand for artificial organs and bionic implants arises from the need to replace or support the functioning of damaged or non-functional organs. the increasing prevalence of chronic diseases, technological advancements, the aging population, growing awareness, and supportive policies have collectively acted as significant drivers for the Artificial Organs & Bionic Implants market.

Artificial Organs and Bionic Implants Market was valued at USD 35,000 Million in 2022 and is expected to grow at a CAGR of around 10% from 2023-2030.

Based on the Type, the market is segmented into artificial organs and Bionics. The artificial organs category hold considerable share of the market in 2022. The segment is experiencing growth primarily due to the increasing demand for kidney, heart, lung, and liver transplants. For Instance, as per the data of Organ Procurement & Transplantation Network, there were totals of 24,669 kidney transplants, 9,236 liver transplants and 3,817 heart transplants in US. In the United States, the average median waiting time for a kidney transplant is approximately 5 years. Consequently, manufacturers have been motivated to address the challenge of meeting the unmet demand by developing innovative solutions such as bio-lungs, artificial pancreas, and wearable artificial kidneys.

Based on Technology, the market is categorized into Mechanical and Electronic. Among these, the Mechanical category held a significant share of the market in 2022. Mechanical artificial organs can be used to assist individuals with congenital disabilities or birth defects. For instance, a prosthetic device can help someone with a missing hand to perform daily tasks and lead a more independent life.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Peripheral Pulse Oximeters Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include: ABIOMED; Berlin Heart; Zimmer Biomet; Boston Scientific Corporation; Cochlear Ltd.; Edwards Lifesciences Corporation; Ekso Bionics; Medtronic; Jarvik Heart, Inc; and SynCardia Systems, LLC. etc.